How many institutions held CMND - Clearmind Medicine Inc. - Common Shares, no par value per share in Q3 2024?

8 institutional investors reported CMND - Clearmind Medicine Inc. - Common Shares, no par value per share for Q3 2024. Use the holders table for investor-level position and value details.

Clearmind Medicine Inc. - Common Shares, no par value per share (CMND)

Q: What does CUSIP 185053402 represent in this 13F holders report?

CUSIP 185053402 is the security identifier for CMND - Clearmind Medicine Inc. - Common Shares, no par value per share used to aggregate holder disclosures.

CUSIP: 185053402

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class: Equity / Common Shares, no par value per share
Shares outstanding: 2,174,400
Total 13F shares: 702,419
Share change: +536,623
Total reported value: $5,494,319
Price per share: $1.22
Number of holders: 8
Value change: +$5,284,113
Number of buys: 6
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 185053402?
CUSIP 185053402 identifies CMND - Clearmind Medicine Inc. - Common Shares, no par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2024
Previous quarter: Q2 2024

Recent filing periods for CUSIP 185053402:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of CMND - Clearmind Medicine Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
AdvisorShares Investments LLC	13F	Company	5.9%	128,641	$213,544	—	30 Jun 2024	13F
Cornerstone Wealth Group, LLC	13F	Company	0.92%	20,000	$33,600	—	30 Jun 2024	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.76%	16,586	$27,864	—	30 Jun 2024	13F
ROYAL BANK OF CANADA	13F	Company	0.03%	569	$1,000	—	30 Jun 2024	13F

Institutional Holders of Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) as of Q3 2024

As of 30 Sep 2024, Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 702,419 shares. The largest 8 holders included Gotham Asset Management, LLC, AdvisorShares Investments LLC, UBS Group AG, Cornerstone Wealth Group, LLC, CITADEL ADVISORS LLC, HRT FINANCIAL LP, Royal Bank of Canada, and NATIONAL BANK OF CANADA /FI/. This page lists 8 institutional shareholders reporting positions in this security for the Q3 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders

Q3 2024 holders

Holder diff

Investor	Q2 2024 Shares	Q3 2024 Shares	Share Diff	Share Chg %	Q2 2024 Value $	Q3 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.